Skip to Main Content

Paper Details

Response to "High CD44 expression is not a prognosis marker in patients with high-risk neuroblastoma".
EBioMedicine
0
2020
Author NameAffiliation
Francisco M De La VegaUniversidad de Sevilla and Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla
  • 1 - 1

Datasets

Release 1.2